4//SEC Filing
Clayton Russell 4
Accession 0001062993-23-014993
CIK 0001374690other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:15 PM ET
Size
5.5 KB
Accession
0001062993-23-014993
Insider Transaction Report
Form 4
Clayton Russell
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-17+180,000→ 180,000 totalExercise: $3.22Exp: 2033-07-17→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on July 17, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
Issuer
Larimar Therapeutics, Inc.
CIK 0001374690
Entity typeother
Related Parties
1- filerCIK 0001530072
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:15 PM ET
- Size
- 5.5 KB